Peritoneal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases
Conditions:   Malignant Peritoneal Effusion;   Malignant Ascites;   Serous Cavity Metastatises Intervention:   Biological: Dual-targeting VEGFR1 and PD-L1 CAR-T cells Sponsor:   Sichuan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2022 Category: Research Source Type: clinical trials